| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.194 | 38.791 | 41.120 | 47.133 | 59.046 | 64.768 | 69.778 | 79.743 | 100.931 | 119.758 |
| Total Income - EUR | 38.546 | 38.824 | 41.155 | 47.135 | 59.118 | 66.842 | 69.891 | 79.751 | 101.759 | 122.407 |
| Total Expenses - EUR | 18.095 | 21.023 | 24.386 | 25.125 | 24.842 | 29.377 | 31.190 | 34.713 | 37.946 | 40.747 |
| Gross Profit/Loss - EUR | 20.450 | 17.800 | 16.769 | 22.011 | 34.277 | 37.465 | 38.701 | 45.038 | 63.813 | 81.660 |
| Net Profit/Loss - EUR | 19.294 | 17.404 | 16.357 | 21.584 | 33.778 | 37.107 | 38.183 | 44.448 | 62.977 | 78.538 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Szalkaymed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.583 | 1.347 | 1.108 | 6.987 | 6.851 | 3.371 | 1.142 | 1.071 | 552 | 13.221 |
| Current Assets | 19.053 | 17.361 | 16.692 | 27.662 | 28.923 | 37.539 | 39.327 | 45.520 | 65.353 | 70.593 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 116 | 0 | 0 | 0 |
| Receivables | 3.378 | 3.256 | 3.902 | 3.522 | 5.108 | 5.552 | 7.940 | 7.281 | 14.966 | 910 |
| Cash | 15.675 | 14.105 | 12.790 | 24.139 | 23.814 | 31.988 | 31.270 | 38.239 | 50.387 | 69.683 |
| Shareholders Funds | 19.348 | 17.458 | 16.410 | 33.169 | 33.828 | 37.157 | 38.231 | 44.497 | 63.026 | 80.640 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.289 | 1.251 | 1.391 | 1.480 | 1.946 | 3.753 | 2.238 | 2.094 | 2.878 | 3.174 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Szalkaymed S.r.l.